X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9768) 9768
Book Review (1491) 1491
Publication (405) 405
Book / eBook (49) 49
Conference Proceeding (28) 28
Book Chapter (27) 27
Magazine Article (20) 20
Dissertation (8) 8
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (9597) 9597
humans (9524) 9524
index medicus (9123) 9123
uterine cervical neoplasms - drug therapy (4714) 4714
adult (3821) 3821
middle aged (3698) 3698
oncology (3547) 3547
cervical cancer (3413) 3413
uterine cervical neoplasms - pathology (3387) 3387
cancer (2612) 2612
aged (2424) 2424
obstetrics & gynecology (1807) 1807
uterine cervical neoplasms - radiotherapy (1804) 1804
chemotherapy (1415) 1415
antineoplastic combined chemotherapy protocols - therapeutic use (1296) 1296
neoplasm staging (1244) 1244
carcinoma (1183) 1183
carcinoma, squamous cell - drug therapy (1165) 1165
combined modality therapy (1152) 1152
uterine cervical neoplasms - therapy (1149) 1149
animals (1116) 1116
uterine cervical neoplasms - metabolism (1110) 1110
radiotherapy (1107) 1107
treatment outcome (1097) 1097
uterine cervical neoplasms - surgery (1048) 1048
care and treatment (1003) 1003
uterine cervix (975) 975
hela cells (961) 961
cisplatin - administration & dosage (960) 960
apoptosis (926) 926
cisplatin (921) 921
cell line, tumor (904) 904
antineoplastic agents - therapeutic use (872) 872
prognosis (868) 868
abridged index medicus (831) 831
health aspects (814) 814
uterine cervical neoplasms - genetics (776) 776
mice (773) 773
research (752) 752
carcinoma, squamous cell - pathology (740) 740
male (730) 730
uterine cervical neoplasms - virology (727) 727
hysterectomy (697) 697
women (697) 697
apoptosis - drug effects (695) 695
uterine cervical neoplasms - mortality (695) 695
analysis (674) 674
human papillomavirus (670) 670
retrospective studies (661) 661
squamous-cell carcinoma (653) 653
uterine cervical neoplasms - diagnosis (642) 642
risk factors (634) 634
hematology, oncology and palliative medicine (584) 584
radiation-therapy (581) 581
tumors (575) 575
expression (567) 567
radiology, nuclear medicine & medical imaging (555) 555
obstetrics and gynecology (548) 548
aged, 80 and over (540) 540
cervix (539) 539
gynecologic-oncology-group (536) 536
follow-up studies (527) 527
surgery (523) 523
chemotherapy, adjuvant (518) 518
antineoplastic agents - pharmacology (512) 512
adenocarcinoma - drug therapy (510) 510
pregnancy (509) 509
carcinoma, squamous cell - radiotherapy (507) 507
uterine cervical neoplasms - prevention & control (494) 494
therapy (492) 492
cell proliferation - drug effects (481) 481
disease-free survival (467) 467
survival rate (465) 465
pharmacology & pharmacy (462) 462
time factors (457) 457
papillomavirus infections (454) 454
cisplatin - therapeutic use (445) 445
adolescent (435) 435
survival (431) 431
dose-response relationship, drug (425) 425
prospective studies (425) 425
antineoplastic agents - administration & dosage (412) 412
antineoplastic combined chemotherapy protocols - adverse effects (406) 406
diagnosis (404) 404
uterine cervical neoplasms - epidemiology (398) 398
young adult (396) 396
neoplasm recurrence, local - drug therapy (395) 395
metastasis (392) 392
neoadjuvant chemotherapy (388) 388
adenocarcinoma - pathology (385) 385
medicine & public health (385) 385
survival analysis (370) 370
proteins (366) 366
biochemistry & molecular biology (364) 364
breast-cancer (362) 362
uterine neoplasms - drug therapy (362) 362
drug therapy (360) 360
drug administration schedule (354) 354
lymphatic metastasis (349) 349
neoadjuvant therapy (349) 349
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8856) 8856
Japanese (295) 295
German (186) 186
Russian (123) 123
French (109) 109
Chinese (94) 94
Italian (50) 50
Spanish (35) 35
Bulgarian (26) 26
Polish (25) 25
Czech (13) 13
Hungarian (7) 7
Portuguese (7) 7
Korean (5) 5
Ukrainian (5) 5
Danish (4) 4
Dutch (4) 4
Swedish (4) 4
Finnish (3) 3
Norwegian (3) 3
Romanian (3) 3
Bosnian (2) 2
Hebrew (2) 2
Serbian (2) 2
Croatian (1) 1
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 734 - 743
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin | Index Medicus
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 6, pp. 770 - 780
Abstract Although anti-HER2 (human epidermal growth factor receptor 2) therapy is currently approved for breast, gastric, and gastroesophageal cancers... 
Hematology, Oncology and Palliative Medicine | Human epidermal growth factor 2 | Pertuzumab | Afatinib | Target therapy | Lapatinib | Ado-trastuzumab emtansine | Trastuzumab | Cancer | GYNECOLOGIC-ONCOLOGY-GROUP | IN-SITU HYBRIDIZATION | UROTHELIAL BLADDER-CANCER | CELL LUNG-CANCER | GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | SALIVARY DUCT CARCINOMA | ONCOLOGY | METASTATIC BREAST-CANCER | AFATINIB BIBW 2992 | GENE AMPLIFICATION | Neoplasms - metabolism | Up-Regulation | Receptor, ErbB-2 - genetics | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Male | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Maytansine - pharmacology | Breast Neoplasms - metabolism | Peritoneal Neoplasms - drug therapy | Uterine Cervical Neoplasms - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Adult | Female | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Peritoneal Neoplasms - secondary | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Uterine Cervical Neoplasms - drug therapy | Clinical Trials as Topic | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Gene Amplification | Quinazolines - therapeutic use | Peritoneal Neoplasms - metabolism | Protein Kinase Inhibitors - pharmacology | Mutation | Quinazolines - pharmacology | Care and treatment | Biological products | Epidermal growth factor | Lung cancer, Non-small cell | Health aspects | Index Medicus
Journal Article
Journal Article
by Burk, Robert D and Chen, Zigui and Saller, Charles and Tarvin, Katherine and Carvalho, Andre L and Scapulatempo-Neto, Cristovam and Silveira, Henrique C and Fregnani, José H and Creighton, Chad J and Anderson, Matthew L and Castro, Patricia and Wang, Sophia S and Yau, Christina and Benz, Christopher and Gordon Robertson, A and Mungall, Karen and Lim, Lynette and Bowlby, Reanne and Sadeghi, Sara and Brooks, Denise and Sipahimalani, Payal and Mar, Richard and Ally, Adrian and Clarke, Amanda and Mungall, Andrew J and Tam, Angela and Lee, Darlene and Chuah, Eric and Schein, Jacqueline E and Tse, Kane and Kasaian, Katayoon and Ma, Yussanne and Marra, Marco A and Mayo, Michael and Balasundaram, Miruna and Thiessen, Nina and Dhalla, Noreen and Carlsen, Rebecca and Moore, Richard A and Holt, Robert A and Jones, Steven J. M and Wong, Tina and Pantazi, Angeliki and Parfenov, Michael and Kucherlapati, Raju and Hadjipanayis, Angela and Seidman, Jonathan and Kucherlapati, Melanie and Ren, Xiaojia and Xu, Andrew W and Yang, Lixing and Park, Peter J and Lee, Semin and Rabeno, Brenda and Huelsenbeck-Dill, Lori and Borowsky, Mark and Cadungog, Mark and Iacocca, Mary and Petrelli, Nicholas and Swanson, Patricia and Ojesina, Akinyemi I and Ojesina, Akinyemi I and Ojesina, Akinyemi I and Le, Xuan and Sandusky, George and Adebamowo, Sally N and Akeredolu, Teniola and Adebamowo, Clement and Reynolds, Sheila M and Shmulevich, Ilya and Shelton, Candace and Crain, Daniel and Mallery, David and Curley, Erin and Gardner, Johanna and Penny, Robert and Morris, Scott and Shelton, Troy and Liu, Jia and Lolla, Laxmi and Chudamani, Sudha and Wu, Ye and Birrer, Michael and McLellan, Michael D and Bailey, Matthew H and Miller, Christopher A and Wyczalkowski, Matthew A and Fulton, Robert S and Fronick, Catrina C and Lu, Charles and Mardis, Elaine R and Appelbaum, Elizabeth L and Schmidt, Heather K and Fulton, Lucinda A and Cordes, Matthew G and Li, Tiandao and Ding, Li and Wilson, Richard K and Rader, Janet S and Behmaram, Behnaz and ... and Canc Genome Atlas Res Network and Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University and Research Institute at Nationwide Children's Hospital and University of Alabama at Birmingham and McDonnell Genome Institute at Washington University and Washington University in St Louis and University of Wisconsin School of Medicine &Public Health and National Hospital, Abuja, Nigeria and Baylor College of Medicine and Barretos Cancer Hospital and Indiana University School of Medicine and Ontario Tumour Bank, The Ottawa Hospital and Massachusetts General Hospital and University of New Mexico Health Sciences Center and National Institute on Deafness &Other Communication Disorders and University of North Carolina at Chapel Hill and Buck Institute for Research on Aging and Cancer Genome Atlas Research Network and Medical College of Wisconsin and University of Abuja Teaching Hospital and University of Oklahoma Health Sciences Center and Institute of Human Virology and St Joseph's Candler Health System and University of Pittsburgh and University of Texas MD Anderson Cancer Center and National Cancer Institute and Montefiore Medical Center and University of Southern California and Institute for Systems Biology and University of Washington and Analytical Biological Services and Harvard Medical School and National Human Genome Research Institute and Memorial Sloan Kettering Cancer Center and Medical University of South Carolina and Ontario Tumour Bank, London Health Sciences Centre and SRA International and University of Kansas Medical Center and University of Lausanne and ILSbio, LLC and University of Bergen and University of California, Irvine and Canada's Michael Smith Genome Sciences Centre and International Genomics Consortium and Oregon Health &Science University and NantOmics and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and University of São Paulo, Ribeir ão Preto Medical School and HudsonAlpha Institute for Biotechnology and Albert Einstein College of Medicine and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center and National Institute of Environmental Health Sciences and Van Andel Research Institute and Ontario Tumour Bank, Ontario Institute for Cancer Research and University of California Santa Cruz and Beckman Research Institute of City of Hope and Leidos Biomedical and Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services and The Cancer Genome Atlas Research Network
Nature, ISSN 0028-0836, 03/2017, Volume 543, Issue 7645, pp. 378 - 384
Cervical cancer remains one of the leading causes of cancer-related deaths worldwide. Here we report the extensive molecular characterization of 228 primary... 
TRANSCRIPTION FACTORS | BREAST-CANCER | TO-MESENCHYMAL TRANSITION | ACCURATE | DNA METHYLATION | RNA-SEQ | MULTIDISCIPLINARY SCIENCES | 14-3-3-SIGMA | RESISTANCE | EXPRESSION | SIGNATURE | Receptors, Transforming Growth Factor beta - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Carcinoma, Squamous Cell - genetics | Genomics | Humans | APOBEC-1 Deaminase - genetics | Phosphatidylinositol 3-Kinases - metabolism | Molecular Targeted Therapy | Caspase 8 - genetics | Mitogen-Activated Protein Kinase Kinases - metabolism | Human papillomavirus 16 - isolation & purification | Receptor, Transforming Growth Factor-beta Type II | Female | Adenocarcinoma - genetics | Nuclear Proteins - genetics | Protein-Serine-Threonine Kinases - metabolism | PTEN Phosphohydrolase - genetics | Signal Transduction | Programmed Cell Death 1 Ligand 2 Protein - genetics | Protein-Serine-Threonine Kinases - genetics | Uterine Cervical Neoplasms - drug therapy | RNA, Long Noncoding - genetics | Receptor, ErbB-3 - genetics | Transcription Factors - genetics | Uterine Cervical Neoplasms - genetics | Virus Integration | B7-H1 Antigen - genetics | Receptors, Transforming Growth Factor beta - metabolism | HLA-A Antigens - genetics | Proteomics | Mutation | Keratins - genetics | Human papillomavirus 16 - genetics | Uterine Cervical Neoplasms - classification | Causes of | Care and treatment | Genetic aspects | Gene mutations | Health aspects | Cervical cancer | Human papillomavirus | Gynecology | Molecular biology | Cancer therapies | Tumors | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 11/2017, Volume 99, Issue 4, pp. 1039 - 1047
Journal Article
Cancer research, ISSN 0008-5472, 2013, Volume 73, Issue 8, pp. 2480 - 2492
Current therapy of gynecologic malignancies consists of platinum-containing chemotherapy. Resistance to therapy is associated with increased levels of... 
CELL LUNG-CANCER | RECURRENT CERVICAL-CANCER | CYCLOOXYGENASE-2 COX-2 | ONCOLOGY | CISPLATIN-DNA-ADDUCTS | INHIBITORY FACTOR | EXPRESSION | EPITHELIAL OVARIAN-CANCER | ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY | T-CELLS | SIGNAL TRANSDUCER | Antigen-Presenting Cells - cytology | Dinoprostone - biosynthesis | Monocytes - cytology | Dendritic Cells - immunology | Humans | STAT Transcription Factors - metabolism | Culture Media, Conditioned - pharmacology | NF-kappa B - metabolism | Antineoplastic Agents - therapeutic use | Monocytes - immunology | Receptors, Interleukin-6 - antagonists & inhibitors | Carboplatin - therapeutic use | Uterine Cervical Neoplasms - metabolism | Dendritic Cells - drug effects | Female | Antineoplastic Agents - pharmacology | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Macrophages - immunology | Cell Survival - drug effects | Antigen-Presenting Cells - drug effects | Uterine Cervical Neoplasms - immunology | Uterine Cervical Neoplasms - drug therapy | Cisplatin - pharmacology | Macrophages - cytology | Antigen-Presenting Cells - immunology | Neoplasms - drug therapy | Monocytes - drug effects | Tumor Microenvironment - immunology | Cisplatin - therapeutic use | Signal Transduction - drug effects | Cell Differentiation - drug effects | Neoplasms - immunology | Cell Line, Tumor | Interleukin-6 - biosynthesis | Macrophages - drug effects | Dendritic Cells - cytology | DNA Damage | Carboplatin - pharmacology | Ovarian Neoplasms - immunology | Receptors, Interleukin-6 - metabolism | Index Medicus
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 231 - 238
Abstract Objective Since the Group Européen de Curiethérapie and the European Society for Radiotherapy and Oncology (GEC–ESTRO) published recommendations for... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Image-guided brachytherapy | GEC–ESTRO guidelines | Primary chemoradiation | Radiotherapy | Survival | Cervical cancer | GEC-ESTRO guidelines | TANDEM-OVOID APPLICATORS | PARAMETERS | INTRACAVITARY BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | ADAPTIVE BRACHYTHERAPY | OBSTETRICS & GYNECOLOGY | VIENNA APPLICATOR | PDR BRACHYTHERAPY | ONCOLOGY | RECOMMENDATIONS | PROGNOSTIC-FACTOR ANALYSES | Adenocarcinoma - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Adenosquamous - drug therapy | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Squamous Cell - radiotherapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Imaging, Three-Dimensional | Adenocarcinoma - radiotherapy | Carcinoma, Adenosquamous - pathology | Uterine Cervical Neoplasms - radiotherapy | Brachytherapy - methods | Neoplasm Recurrence, Local | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Carcinoma, Adenosquamous - radiotherapy | Disease-Free Survival | Magnetic Resonance Imaging | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Radiotherapy, Image-Guided - methods | Aged | Neoplasm Staging | Cancer patients | Care and treatment | Radioisotope brachytherapy | Comparative analysis | Patient outcomes | Index Medicus
Journal Article